Lista de obras -

A new human immunodeficiency virus derived from gorillas

artículo científico publicado en 2009

A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain

article

A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes

artículo científico publicado en 2003

Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavir

artículo científico publicado en 2002

Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma

artículo científico publicado en 2006

Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression

artículo científico publicado en 2012

Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide

artículo científico publicado en 2010

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

article

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

artículo científico publicado en 2015

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France

scientific article published on February 2008

Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

article

Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates

artículo científico publicado en 2017

Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

artículo científico publicado en 2002

Differences in proviral DNA load between HIV-1- and HIV-2-infected patients

article

Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program

artículo científico publicado en 2015

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen ⬇️

artículo científico publicado el 13 de noviembre de 2011

Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads

artículo científico publicado en 2018

Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes

artículo científico publicado en 2007

Evidence of Sexual Transmission of Zika Virus

artículo científico publicado en 2016

Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort

artículo científico publicado en 2003

Failure of HIV-2 viral load assay in a severely immunodeficient patient: clinical and therapeutic management issues

scientific article published on 15 November 2005

First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).

artículo científico publicado en 2018

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure.

artículo científico publicado en 2009

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.

artículo científico publicado en 2011

Genotypic resistance profiles of HIV-2-treated patients in West Africa

artículo científico publicado en 2014

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

artículo científico publicado en 2009

HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man

article

HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients

artículo científico publicado en 2014

HIV-2 infection and HIV-associated nephropathy

artículo científico publicado en 2006

High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen

artículo científico publicado en 2004

High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients

artículo científico publicado en 2015

Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection

artículo científico publicado en 2013

Hiv-2 molecular epidemiology

artículo científico publicado en 2016

Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir

artículo científico publicado en 2010

Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification

artículo científico publicado en 2004

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients

article

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group

artículo científico publicado en 2011

Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl

artículo científico publicado en 2009

Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test

artículo científico publicado en 2007

Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.

artículo científico publicado en 2011

Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations

artículo científico publicado en 2003

Impact of freezing/thawing technique on sperm DNA integrity in HIV-1 patients.

artículo científico publicado en 2010

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

artículo científico publicado en 2013

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial

artículo científico publicado en 2002

Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay

artículo científico publicado en 2005

In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors

artículo científico publicado en 2011

In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors

artículo científico publicado en 2008

In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572.

artículo científico publicado en 2010

Integrase polymorphism and HIV-1 group O diversity

article

Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptors

artículo científico publicado en 2004

Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies

artículo científico publicado en 2017

Letter. In vitro phenotypic susceptibility to nucleoside reverse transcriptase inhibitors of HIV-2 isolates with the Q151M mutation in the reverse transcriptase gene

artículo científico publicado en 2005

Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.

artículo científico publicado en 2011

Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients

artículo científico publicado en 2018

Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool

artículo científico publicado en 2011

Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load

artículo científico publicado en 2017

Multicenter quality control of the detection of HIV-1 genome in semen before medically assisted procreation

artículo científico publicado en 2006

New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification

artículo científico

New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load

artículo científico publicado en 2014

No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort

artículo científico publicado en 2006

One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?

article

Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections

artículo científico publicado en 2015

Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome

artículo científico publicado en 2012

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women

artículo científico publicado en 2015

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration

artículo científico publicado en 2015

Plasma RNA quantification and HIV-1 divergent strains.

artículo científico publicado en 2003

Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections

artículo científico publicado en 2002

Plasma viral RNA assay in HIV-1 group O infection by real-time PCR.

artículo científico publicado en 2003

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients

artículo científico publicado en 2013

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006

artículo científico publicado en 2007

Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients

artículo científico publicado en 2012

Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection

artículo científico publicado en 2006

Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.

artículo científico publicado en 2008

Quantification of proviral DNA load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.

artículo científico publicado en 2005

Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR.

artículo científico publicado en 2004

Rare selection of the K65R mutation in antiretroviral-naive patients failing a first-line abacavir/ lamivudine-containing HAART regimen

artículo científico publicado en 2006

Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections

artículo científico publicado en 2015

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.

artículo científico publicado en 2004

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen

artículo científico publicado en 2008

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.

artículo científico publicado en 2015

The first reported case and management of multicentric Castleman??s disease associated with Kaposi??s sarcoma in an HIV-2-infected patient

article

The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection

artículo científico publicado en 2009

Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy

artículo científico publicado en 2014

Transmitted drug resistance in French HIV-2-infected patients

artículo científico publicado en 2013

Tropism distribution among antiretroviral-naive HIV-2-infected patients

artículo científico publicado en 2015

Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study

artículo científico publicado en 2012

Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients

article

Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study

artículo científico publicado en 2016

Lista de obras de

A new human immunodeficiency virus derived from gorillas

A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain

A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes

Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavir

Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma

Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression

Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France

Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates

Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Differences in proviral DNA load between HIV-1- and HIV-2-infected patients

Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen ⬇️

Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads

Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes

Evidence of Sexual Transmission of Zika Virus

Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort

Failure of HIV-2 viral load assay in a severely immunodeficient patient: clinical and therapeutic management issues

First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure.

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.

Genotypic resistance profiles of HIV-2-treated patients in West Africa

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man

HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients

HIV-2 infection and HIV-associated nephropathy

High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen

High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients

Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection

Hiv-2 molecular epidemiology

Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir

Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group

Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl

Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test

Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.

Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations

Impact of freezing/thawing technique on sperm DNA integrity in HIV-1 patients.

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial

Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay

In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors

In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors

In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572.

Integrase polymorphism and HIV-1 group O diversity

Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptors

Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies

Letter. In vitro phenotypic susceptibility to nucleoside reverse transcriptase inhibitors of HIV-2 isolates with the Q151M mutation in the reverse transcriptase gene

Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.

Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients

Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool

Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load

Multicenter quality control of the detection of HIV-1 genome in semen before medically assisted procreation

New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification

New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load

No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort

One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?

Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections

Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration

Plasma RNA quantification and HIV-1 divergent strains.

Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections

Plasma viral RNA assay in HIV-1 group O infection by real-time PCR.

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006

Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients

Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection

Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.

Quantification of proviral DNA load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.

Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR.

Rare selection of the K65R mutation in antiretroviral-naive patients failing a first-line abacavir/ lamivudine-containing HAART regimen

Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen